+499.5%
MRNA vs EL
+14.8%
+484.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +3.0% | -5.2% | -6.9% |
| 7D | +5.5% | +0.8% | +4.7% | +3.4% |
| 30D | +158.7% | +19.8% | +138.9% | +115.3% |
| 3M | +182.1% | +25.7% | +156.4% | +129.9% |
| 6M | +151.8% | +5.4% | +146.4% | +117.4% |
| YTD | +393.6% | +0.2% | +393.3% | +329.5% |
| 1Y | +499.5% | +20.4% | +479.0% | +388.3% |
| All | +499.5% | +14.8% | +484.7% | +388.3% |
Cumulative growth
Daily Returns
Daily percentage return beside EL.
Daily Out/Under-Performance
Portfolio return minus EL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling